Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral ...
Feb 6, 2024
0
48
As the global population ages, more and more research is focusing on the effects of multimorbidity: the presence of two or more long-term health conditions.
Jan 30, 2024
0
0
In Wuhan, China, a stringent lockdown was implemented to contain the spread of COVID-19, transitioning to a normalized prevention and control strategy. Considering the shared transmission route through the respiratory tract, ...
Jan 29, 2024
0
0
Researchers from seven Environment for Development (EfD) centers plus the EfD Global Hub, located at the University of Gothenburg, have conducted an extensive survey on how serious people perceive COVID-19.
Jan 26, 2024
0
20
Less is also better—that is what researchers have found while conducting a tri-nation clinical trial to see if shorter courses of antibiotics are as effective as longer prescriptions of the drug to treat ventilator-associated ...
Jan 26, 2024
1
0
New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they ...
Jan 24, 2024
0
129
The chronic lung disease bronchopulmonary dysplasia (BPD) affects a significant number of infants who were born early and have underdeveloped lungs. They typically require lengthy specialized care in a neonatal intensive ...
Jan 20, 2024
0
2
Cytokines are chemical messengers that help the body get rid of invading bacteria and viruses, and control inflammation. The body carefully balances cytokines because they help keep the immune system healthy. However, this ...
Jan 17, 2024
0
54
Rupak Datta, MD, Ph.D., MPH, is an assistant professor of medicine (infectious diseases) at Yale School of Medicine (YSM) and an assistant hospital epidemiologist in the Veterans Affairs Connecticut Healthcare System. His ...
Jan 17, 2024
0
14
The Therapeutic Goods Administration (TGA) has approved a vaccine against respiratory syncytial virus (RSV) in Australia for the first time. The shot, called Arexvy and manufactured by GSK, will be available by prescription ...
Jan 17, 2024
0
0
